Impact of Regional Anesthesia on Inflammatory Mechanisms During Vaso-occlusive Crisis in Sickle Cell Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire de la Guadeloupe

About this trial

Sickle cell disease is a chronic disease characterized by multiple vaso-occlusive complications. The basic treatment for patients with a vaso-occlusive crisis (VOC) is based on adequate hydration, oxygen therapy and pain control. Loco Regional Anesthesia (LRA) is one of the major treatments in resuscitation anesthesia for both anesthesia and analgesia. LRA allows effective and almost immediate pain control by blocking nerve afferents in a given area. LRA could decrease the inflammatory response during crises and accelerate resolution of the crisis.

Eligibility criteria

Qualifiers

patients adult >18 years

patients with vaso-occlusive crisis

Disqualifiers

Pregnant or breastfeeding women

Blood transfusion within the last 3 months

Lack of affiliation with the French social security system

Protected individuals

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

34 Participants
are grouped into 2 trial groups